Arteritis de células gigantes: ¿Cómo debutan pacientes chilenos?. Análisis de casos y revisión de la literatura.

Autores/as

  • Pamela Wurmann Hospital Clinico Universidad de Chile
  • Claudia Hernández Hospital Clinico Universidad de Chile
  • Pedro Zamorano Hospital Clinico Universidad de Chile
  • Francisca Sabugo Hospital Clinico Universidad de Chile
  • Claudio Karsulovic Hospital Clinico Universidad de Chile
  • Macarena Mac-Namara Hospital Clínico Universidad de Chile

Palabras clave:

Giant Cell Arteritis, Systemic Vasculitis, Temporal Arteries

Resumen

Background: Giant cell Arteritis (GCA) is the most common systemic vasculitis in patients over 50 years. Diagnosis is based on clinical, laboratory, imaging, and biopsy. Temporal artery biopsy (TAB) may be inconclusive in up to 40% of patients. Aim: To describe disease features of patients diagnosed with GCA. Material and Methods: Review of pathology reports of giant cell arteritis and clinical records of patients seen with the diagnosis between 2000 and 2019. Demographic, clinical, laboratory, histopathology, imaging, treatment, and follow-up variables were analyzed. Results: We fetched 32 patients with a median age at diagnosis of 70.5 years (range 57-90), 81% women. Twenty eight percent had polymyalgia. 72% had only cranial symptoms, 12% had extracranial involvement and 13% exclusive extracranial involvement. The median time from onset of symptoms to diagnosis was two months (range 0.5-8). All had elevated erythrocyte sedimentation rate and c reactive protein. A TAB was performed in 27 patients and in 17 (65.4%) it confirmed the diagnosis. Transmural inflammation was the most frequent finding. All patients received steroids. Follow-up information was available from 25 patients and 92% received a steroid-sparing agent, usually methotrexate (74%). Ninety two percent achieved clinical remission in the first year and 59% had minor relapses during steroid tapering. Conclusions: Our patients showed frequent extracranial involvement and TAB was a useful diagnostic tool.

Biografía del autor/a

Pamela Wurmann, Hospital Clinico Universidad de Chile

Profesor asociado. Departamento de Medicina. Sección Reumatología Hospital Clínico Universidad de Chile

Claudia Hernández, Hospital Clinico Universidad de Chile

Becada Reumatología Hospital Clínico Universidad de Chile

Pedro Zamorano, Hospital Clinico Universidad de Chile

Becado Reumatología Hospital Clínico Universidad de Chile

Francisca Sabugo, Hospital Clinico Universidad de Chile

Profesor asociado. Departamento de Medicina. Sección Reumatología Hospital Clínico Universidad de Chile

Claudio Karsulovic, Hospital Clinico Universidad de Chile

Becado de Reumatología Hospital Clínico Universidad de Chile

Macarena Mac-Namara, Hospital Clínico Universidad de Chile

Becado de Reumatología Hospital Clínico Universidad de Chile

Descargas

Publicado

2022-01-14

Cómo citar

Wurmann, P., Hernández, C., Zamorano, P., Sabugo, F., Karsulovic, C., & Mac-Namara, M. (2022). Arteritis de células gigantes: ¿Cómo debutan pacientes chilenos?. Análisis de casos y revisión de la literatura. Revista Médica De Chile, 150(6). Recuperado a partir de https://revistamedicadechile.cl/index.php/rmedica/article/view/9444

Número

Sección

Artículos de Investigación

Artículos más leídos del mismo autor/a